Delivery Order SPE2DB24D1007-SPE2DB25FCBQS

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,756,127 units of the drug PRADAXA 150 MG CAPSULE. The contract has a firm fixed price ceiling value of $1,334.33 and an ultimate completion date of September 14, 2021. The contract is a delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award, valued at $1,947.96, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a period of performance through March 6, 2023. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,933.40, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.58 firm-fixed-price delivery order is for the provision of 4,561,171,138 units of the prescription medication PRADAXA 150 mg capsules. The contract has a performance period through June 8, 2023 and was awarded on June 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,095.18 firm fixed-price delivery order is for the supply of 150 mg PRADAXA capsules, a medication used to treat cardiovascular conditions. The contract has a period of performance through December 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,941.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of December 1, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
This federal contract award, valued at $4,860.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of June 28, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,094.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a period of performance through January 4, 2024, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract is structured as a Firm Fixed Price Delivery Order, with no specific set-aside designation noted. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.94 firm-fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $6,714.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication, with a completion date of May 10, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCBQS
    Delivery Order

This federal contract award, valued at $1,023.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,143,130 units of the prescription medication PRADAXA 150 MG CAPSULE. The contract is a Firm Fixed Price Delivery Order with a performance period extending through May 6, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The contract award was not set aside for any specific business type.

Generated 8/4/25, 9:53 AM